BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26764186)

  • 1. SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.
    Ensign SP; Roos A; Mathews IT; Dhruv HD; Tuncali S; Sarkaria JN; Symons MH; Loftus JC; Berens ME; Tran NL
    Mol Cancer Res; 2016 Mar; 14(3):302-12. PubMed ID: 26764186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
    Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
    J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function.
    Fortin SP; Ennis MJ; Savitch BA; Carpentieri D; McDonough WS; Winkles JA; Loftus JC; Kingsley C; Hostetter G; Tran NL
    Mol Cancer Res; 2009 Nov; 7(11):1871-81. PubMed ID: 19861406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.
    Fortin SP; Ennis MJ; Schumacher CA; Zylstra-Diegel CR; Williams BO; Ross JT; Winkles JA; Loftus JC; Symons MH; Tran NL
    Mol Cancer Res; 2012 Jul; 10(7):958-68. PubMed ID: 22571869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
    Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA
    Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
    Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL
    Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling.
    Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H
    Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HB-EGF is associated with DNA damage and Mcl-1 turnover in human glioma cell lines treated by Temozolomide.
    Séry Q; Rabé M; Oliver L; Vallette FM; Gratas C
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1377-1383. PubMed ID: 28970067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
    Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic TRADD confers a worse prognosis in glioblastoma.
    Chakraborty S; Li L; Tang H; Xie Y; Puliyappadamba VT; Raisanen J; Burma S; Boothman DA; Cochran B; Wu J; Habib AA
    Neoplasia; 2013 Aug; 15(8):888-97. PubMed ID: 23908590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM; Lee DW; Jung JU; Sitcheran R
    Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
    Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
    Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
    Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.
    Lu C; Cui C; Liu B; Zou S; Song H; Tian H; Zhao J; Li Y
    Neurosci Lett; 2017 Sep; 657():77-83. PubMed ID: 28778805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.